
Ins & Outs: Biopharma players shuffle c-suite ranks
Galapagos NV The biotechnology company specializing in chimeric antigen receptor (CAR-Ts) has announced that Paul Stoffels will step down as its CEO while he continues as the non-executive chair of the board of directors. The board expects to appoint …